Clinical Trial

Optilume Registry for Treatment of Stricture of the Anterior Urethra

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this registry is verifying the continued safety and effectiveness of the Optilume DCB clinical use in patients undergoing dilation of the urethral stricture.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-28; most recent amendment 2025-02-21.
Status change: Recruiting → Active, Not Recruiting 2025-02-21
Status change: Not Yet Recruiting → Recruiting 2022-12-08
Trial Details
NCT Number NCT05479422
Lead Sponsor European Association of Urology Research Foundation
Collaborators: Laborie Medical Technologies Inc.
Conditions Anterior Urethral Stricture, Male
Enrollment 150 participants
Start Date 2022-10-13
Primary Completion 2029-08-15 (estimated)
Study Completion 2029-08-15 (estimated)
Updated on ClinicalTrials.gov 2025-02-24